Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Acquired circulating anticoagulants.

¹Department of Medicine, University of California, School of Medicine, Los Angeles.

Hematology/Oncology Clinics of North America

|December 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Same author

Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.

Bone marrow transplantation·1998

Same author

CD34+ cell engraftment, ex vivo expansion, and malignant cell depletion following immunomagnetic selection.

Journal of hematotherapy·1998

Same author

Composition of peripheral blood progenitor cell components collected from healthy donors.

Transfusion·1997

Same author

An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.

Cancer·1996

Same author

Production of anti-erythrocyte antibodies by leukemic and nonleukemic B cells in chronic lymphocytic leukemia patients.

Leukemia & lymphoma·1996

Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026

Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026

Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026

See all related articles

Acquired inhibitors of blood coagulation, also known as acquired anticoagulants, can develop unexpectedly in individuals without prior bleeding issues. Managing these acquired bleeding disorders presents unique challenges for hematologists.

Area of Science:

Hematology
Internal Medicine
Pathology

Background:

Acquired inhibitors of blood coagulation are pathological substances that impede clotting.
While often seen in hereditary bleeding disorders, they can arise de novo.

Purpose of the Study:

To discuss acquired circulating anticoagulants that develop in patients with previously normal hemostasis.
To explore the pathogenesis and management strategies for these conditions.

Main Methods:

Literature review and synthesis of existing knowledge on acquired anticoagulants.
Discussion of clinical presentation, diagnostic approaches, and therapeutic interventions.

Main Results:

Acquired inhibitors can manifest in individuals with no prior history of bleeding disorders.

Related Experiment Videos

These inhibitors directly interfere with clotting factors or their reactions.

Conclusions:

The development of acquired anticoagulants in previously healthy individuals poses significant clinical challenges.
Effective management requires a tailored approach distinct from that for hereditary hemophilia.